Japanese firms Astellas Pharma Inc., Eisai Co., Ltd., Daiichi Sankyo Firm, Restricted, and Takeda Pharmaceutical Firm Restricted have agreed a collaboration to scale back the environmental influence of pharmaceutical packaging.
Based mostly on the settlement, the 4 firms will intention to advertise using extra environmentally-friendly packaging for pharmaceutical merchandise by sharing data on packaging applied sciences to scale back environmental influence, resembling blister packs product of biomass-based plastic as an alternative of petroleum-derived plastic, compact packaging, recycled packaging supplies, and recyclable packaging supplies.
The businesses anticipate to develop this collaboration by calling on different firms to scale back their very own environmental footprint.
Particular person initiatives
Astellas has set “Deepen our engagement in sustainability” as one of many strategic objectives in its Company Strategic Plan 2021. The discount of environmental burden is one in all Astellas’ precedence themes inside sustainability.
Eisai established the “Eisai Environmental Management Vision” this fiscal 12 months, and along with local weather change counter-measures aimed toward attaining carbon neutrality by fiscal 2040, Eisai has shaped a medium- to long-term plan for environmental points together with environment friendly use of water and recycling of assets, and can work to additional advance these efforts.
As a healthcare firm with the Objective “to contribute to the enrichment of high quality of life world wide,” Daiichi Sankyo considers international environmental conservation as a key administration challenge and promotes environmental administration.
At Takeda, “Objective-led Sustainability” is about creating each enterprise and societal worth by means of its core enterprise. Takeda continues to scale back its operational carbon footprint and is now dedicated to attaining net-zero GHG emissions for scopes 1 and a couple of earlier than 2035 and for Scope 3 earlier than 2040.